Alex Viveros

@alexviveros.bsky.social

Town and Health Reporter at the Jackson Hole News&Guide. Former intern at Science News, Chemical & Engineering News, and Science Magazine. Reach me on Signal: alexviveros.01 alexgviveros.com

I wrote about Vertex’s suzetrigine, and the science behind developing nonopioid painkillers more generally, for my latest story @cenmag.bsky.social. This is also my final story as C&EN’s Editorial Fellow — more info about my next steps TK!

Laura Howes@laurahowes.bsky.social · 2y ago

The FDA should make a decision on whether or not to approve Vertex Pharmaceuticals suzetrigine today. While an @cenmag.bsky.social editorial fellow, @alexviveros.bsky.social investigated the backstory for us 🧪#chemsky

Two stories in @cenmag.bsky.social this week. I spoke to James Paulson and Ian Wilson at Scripps Research about their new study in Science, which found that one mutation to the hemagglutinin protein of an H5N1 virus switched the protein’s binding specificity from avian- to human-type receptors.

Single mutation to bird flu protein altered receptor specificity in lab

Study reports that wild-type H5N1 hemagglutinin preferentially binds avian-type receptors

cen.acs.org

I’m the current Editorial Fellow at Chemical & Engineering News and a recent graduate of MIT’s science writing program. I mainly write about infectious diseases and the viruses, bacteria, and other little things that cause them. Feel free to DM me with any story ideas (or just to say hi).